MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202517097090 A) filed by Voyager Therapeutics, Inc., Lexington, U.S.A., on Oct. 8, for 'compositions and methods for the treatment of disorders related to cdkl5 deficiency.'

Inventor(s) include Nonnenmacher, Mathieu Emmanuel; Moyer, Tyler Christopher; Li, Jiangyu; and Laks, Dan Richard.

The application for the patent was published on Nov. 21, under issue no. 47/2025.

According to the abstract released by the Intellectual Property India: "The disclosure relates to compositions and methods for altering, e.g., enhancing, the expression of CDKL5 proteins via delivery using an adeno-associated virus (AAV) capsid variant. The compositions and methods of t...